Definitive Contract 75D30122C13953
- Not listed
- The Centers for Disease Control and Prevention (CDC) awarded a $4,429,789.59 firm-fixed-price contract to Quest Diagnostics Incorporated, a large diagnostic information services provider, to maintain approximately 20,000 COVID-19 testing sites nationwide through the Increasing Community Access to Testing (ICATT) program. This contract, which does not have a set-aside designation, is part of the CDC's efforts to increase equitable access to COVID-19 testing by partnering with private sector...
- The Centers for Disease Control and Prevention (CDC) awarded a $103,373,097.28 Firm Fixed Price contract to E3Health Solutions, LLC, a woman-owned small business, to maintain approximately 20,000 pharmacy and community-based COVID-19 testing sites nationwide through June 2028. This contract, known as Increasing Community Access to Testing (ICATT), was previously awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR). The contract does not have a set-aside...
- The Centers for Disease Control and Prevention (CDC) awarded a $529,000 firm fixed-price delivery order contract to Signify Health LLC, doing business as Censeohealth, to provide COVID-19 tests for nursing home residents and staff. As part of the Department of Health and Human Services' (HHS) efforts to respond to the COVID-19 pandemic, the CDC in Pittsburgh utilized its Public Health and Social Services Emergency Fund vehicle to procure testing services from the Dallas, Texas-based prime...
- The Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a $44,450 firm fixed price delivery order to Signify Health LLC, doing business as Censeohealth, a for-profit organization. The delivery order is part of a larger $5 million indefinite delivery contract between the CDC and Signify Health to provide COVID-19 testing services. Under this contract, Signify Health has received multiple delivery orders since May 2020 to supply COVID-19 tests for...
- This contract was awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to Quest Diagnostics Incorporated, a for-profit diagnostic information services provider, for data submission services. The contract is a definitive, firm fixed-price contract with a potential value of $722,500.00. The purpose is to obtain laboratory test order and test result data, including longitudinal patient identifiers but without personally identifiable information, to...
- The Centers for Disease Control and Prevention (CDC) awarded a $39.9 million firm fixed price definitive contract to Aegis Sciences Corporation for COVID-19 genome sequencing services. As the prime contractor, Aegis Sciences Corporation will perform the sequencing work out of its Nashville, Tennessee laboratory. The one year contract is intended to support the CDC's ongoing efforts to track genetic variations of the SARS-CoV-2 virus through genomic surveillance. No subcontractors or set aside...
- This is a $47,916,380.00 definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Laboratory Corporation of America (Labcorp) for serology testing services. The contract has a firm fixed price pricing type and a period of performance through March 5, 2022. The original solicitation was a pre-solicitation for laboratory testing of blood specimens to determine SARS-CoV-2 seroprevalence across the United States. The contract supports the CDC's public health initiatives...
- This definitive contract was awarded by the Centers for Disease Control and Prevention (CDC) to Helix Opco LLC, a for-profit limited liability company located in San Mateo, California. The $81,891,810 firm fixed price contract is for genomic sequencing services to support COVID-19 tracking and research efforts. The contract has an ultimate completion date of April 28, 2025 and was awarded on May 16, 2022. No set-aside designation was used. Helix Opco has previously received other prime contracts...
- This is a $91,693,500.00 firm-fixed-price definitive federal contract awarded by the Centers for Disease Control and Prevention (CDC) to Laboratory Corporation of America (Labcorp), a leading global life sciences company, for COVID-19 laboratory testing services. The contract has an ultimate completion date of April 22, 2025. Labcorp, a for-profit organization headquartered in Burlington, North Carolina, is the prime contractor and does not have any set-aside designation. The contract is not...
- The Centers for Disease Control and Prevention (CDC) awarded a $1.249 million firm fixed price delivery order contract to Laboratory Corporation of America Holdings (LabCorp) for surge serology testing. Under the contract, LabCorp will provide serology testing services to the CDC in Burlington, North Carolina through December 2020 to support the agency's COVID-19 response efforts. No subcontractors or set aside designations were identified. The CDC is a component of the U.S. Department of Health...
The Centers for Disease Control and Prevention, under the Department of Health and Human Services, awarded a definitive contract valued at $2,283,208.20 to Color Health Inc., doing business as Color Genomic Danny. The contract is being performed in Burlingame, California through May 2025 in response to Solicitation ICATT to increase equitable access to COVID-19 testing. Specifically, the prime contractor will provide full end-to-end testing services at no cost to patients through a minimum of 1,000 pharmacy, retail, or community-based testing sites across seven HHS regions, with at least 50% located in high social vulnerability areas. Evaluation criteria included technical approach, past performance, and price. The contract was awarded without a set-aside designation to support the CDC's efforts to maintain approximately 20,000 testing sites through May 2025 as part of the Increasing Community Access to Testing program.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Increasing Community Access to Testing (ICATT) | 75D301-22-C-13957 | Department of Health and Human Services Centers for Disease Control and Prevention | Award Notice 8/8 | 7/8/22, 8:50 AM | |
Increasing Community Access to Testing (ICATT) | 75D301-22-R-72105 | Department of Health and Human Services Centers for Disease Control and Prevention | Solicitation 2/8 | 2/1/22, 2:04 PM | |
Increasing Community Access to Testing (ICATT) | Pre-75D301-22-R-72098 | Department of Health and Human Services Centers for Disease Control and Prevention | Pre-Solicitation 1/8 | 1/7/22, 1:32 PM | |
Increasing Community Access to Testing (ICATT) | 75D301-22-C-13958 | Department of Health and Human Services Centers for Disease Control and Prevention | Award Notice 6/8 | 6/15/22, 1:40 PM | |
Increasing Community Access to Testing (ICATT) | 75D301-22-C-13954 | Department of Health and Human Services Centers for Disease Control and Prevention | Award Notice 4/8 | 6/15/22, 1:39 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00004 | Funding Only Action | ($42m) | 10/23/23 | |
| P00003 | Other Administrative Action | $0 | 3/16/23 | |
| P00002 | Supplemental Agreement for work within scope | $81.7k | 3/1/23 | |
| P00001 | Other Administrative Action | $0 | 11/25/22 | |
| Not listed | Not listed | $44.1m | 6/14/22 |